472 related articles for article (PubMed ID: 28402493)
1. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
2. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
de Boer M; van der Sluis WB; de Boer JP; Overbeek LIH; van Leeuwen FE; Rakhorst HA; van der Hulst RRWJ; Hijmering NJ; Bouman MB; de Jong D
Aesthet Surg J; 2017 Sep; 37(8):NP83-NP87. PubMed ID: 29036941
[TBL] [Abstract][Full Text] [Related]
3. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
[TBL] [Abstract][Full Text] [Related]
4. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
5. [Anaplastic large cell lymphoma associated with breast implants, diagnosed by fine needle aspiration. Report of one case].
Misad S C; Walker B K; Valbuena JR; Guerra S C; Camus A M; Ocqueteau M; Loyola S; Zoroquiain P
Rev Med Chil; 2020 Aug; 148(8):1207-1212. PubMed ID: 33399788
[TBL] [Abstract][Full Text] [Related]
6. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants.
Locke MB; Lofts J
ANZ J Surg; 2017 Oct; 87(10):789-794. PubMed ID: 25827224
[TBL] [Abstract][Full Text] [Related]
7. Achieving Reliable Diagnosis in Late Breast Implant Seromas: From Reactive to Anaplastic Large Cell Lymphoma.
Di Napoli A
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):15S-22S. PubMed ID: 30817552
[TBL] [Abstract][Full Text] [Related]
8. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
[TBL] [Abstract][Full Text] [Related]
9. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
[TBL] [Abstract][Full Text] [Related]
11. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
Di Napoli A; Pepe G; Giarnieri E; Cippitelli C; Bonifacino A; Mattei M; Martelli M; Falasca C; Cox MC; Santino I; Giovagnoli MR
PLoS One; 2017; 12(7):e0181097. PubMed ID: 28715445
[TBL] [Abstract][Full Text] [Related]
12. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring Protocol.
Santanelli di Pompeo F; Laporta R; Sorotos M; Di Napoli A; Giovagnoli MR; Cox MC; Campanale A; Longo B
Plast Reconstr Surg; 2015 Aug; 136(2):144e-151e. PubMed ID: 26218387
[TBL] [Abstract][Full Text] [Related]
13. Commentary on: CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Clemens MW; Miranda RN
Aesthet Surg J; 2017 Jul; 37(7):776-778. PubMed ID: 28402426
[No Abstract] [Full Text] [Related]
14. Commentary on: CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Deva AK
Aesthet Surg J; 2017 Jul; 37(7):779-781. PubMed ID: 28402407
[No Abstract] [Full Text] [Related]
15. Breast Implant-associated Anaplastic Large Cell Lymphoma Diagnosis 6 Years After Implant Removal: A Case Report.
Barnea Y; Clemens MW; Madah E; Arad E; Ben-Ezra J; Haran O
Ann Plast Surg; 2022 Feb; 88(2):157-161. PubMed ID: 34270472
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
Wu D; Allen CT; Fromm JR
Cytometry B Clin Cytom; 2015 Jan; 88(1):58-63. PubMed ID: 25044944
[TBL] [Abstract][Full Text] [Related]
17. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
18. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
19. EURAPS Editorial: BIA-ALCL, a brief overview.
Santanelli di Pompeo F; Sorotos M
J Plast Reconstr Aesthet Surg; 2018 Jun; 71(6):785-787. PubMed ID: 29776552
[No Abstract] [Full Text] [Related]
20. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
